You’re avoiding the point: you claimed the trial was sabotaged by the FDA (it was poor management, not the FDA) because doses were limited to 2, implying that 4 would be needed to be efficacious.
But the story you’re sharing required only 1 dose? So the FDA wasn’t wrong?
Market Data 
Markets 
AI
